Kenshiro Hirata
Ikeda, 8600082, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Lymph node macrophage-targeted interferon alpha boosts anticancer immune responses by regulating CD169-positive phenotype of macrophages.
Journal: Molecular cancer
Published: August 20, 2024
Evaluation for Blood Concentration and Efficacy/Safety of Continuous Administration of Thiamylal in Children.
Journal: Therapeutic drug monitoring
Published: May 15, 2023
Response to "iPTH is not a significant factor influencing the tacrolimus C/D ratio".
Journal: Clinical and translational science
Published: December 16, 2021
High-Sensitivity and High-Throughput Quantification of Everolimus in Human Whole Blood Using Ultrahigh-Performance Liquid Chromatography Coupled With Tandem Mass Spectrometry.
Journal: Therapeutic drug monitoring
Published: December 06, 2021
The Binding of Aripiprazole to Plasma Proteins in Chronic Renal Failure Patients.
Journal: Toxins
Published: October 14, 2021
Association of CYP3A5 polymorphisms and parathyroid hormone with blood level of tacrolimus in patients with end-stage renal disease.
Journal: Clinical and translational science
Published: February 09, 2021
Effect of Cinacalcet on the Redox Status of Albumin in Secondary Hyperparathyroidism Patients Receiving Hemodialysis.
Journal: Biological & pharmaceutical bulletin
Published: October 01, 2020
Effect of Serum Parathyroid Hormone on Tacrolimus Therapy in Kidney Transplant Patients: A Possible Biomarker for a Tacrolimus Dosage Schedule.
Journal: Biological & pharmaceutical bulletin
Published: May 08, 2019
Parathyroid hormone contributes to the down-regulation of cytochrome P450 3A through the cAMP/PI3K/PKC/PKA/NF-κB signaling pathway in secondary hyperparathyroidism.
Journal: Biochemical pharmacology
Published: July 21, 2017
Polythiol-containing, recombinant mannosylated-albumin is a superior CD68+/CD206+ Kupffer cell-targeted nanoantioxidant for treatment of two acute hepatitis models.
Journal: The Journal of pharmacology and experimental therapeutics
Published: November 16, 2014
Possible false-negative results on therapeutic drug monitoring of phenytoin using a particle enhanced turbidimetric inhibition immunoassay in a patient with a high level of IgM.
Journal: Therapeutic drug monitoring
Published: March 18, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026